Id. (footnote omitted).
In re Darvocet, Darvon and Propoxyphene Products Liability Litigation, 2012 WL 2457825, at *1 (E.D. Ky. June 22, 2012) (citation omitted) (“Darvocet II“). Accord Frazier, 2012 WL 6641626, at *6 (refusing to follow Bartlett because “the logic of Mensing is applicable to design defect claims”); Strayhorn, 2012 WL 3261377, at *10 (agreeing with Darvocet II); Purvis, 2012 WL 5364392, at *4 (court “not persuaded” by Bartlett); Pirello, 2012 WL 5363243, at *4 n.3 (same); Lashley v. Pfizer, Inc., ___ F. Supp.2d ___, 2012 WL 2459148, at *9 (S.D. Miss. June 27, 2012) (finding Bartlett “unpersuasive and not a proper basis for relief”).